跳至主要内容
临床试验/NCT04069013
NCT04069013已完成不适用

Randomized Controlled Trial Comparing Surgical Outcomes Following PCNL and Mini PCNL in the Treatment of Kidney Stones

The Cleveland Clinic1 个研究点 分布在 1 个国家目标入组 18 人开始时间: 2022年5月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
18
试验地点
1
主要终点
Blood loss as estimated by postoperative decreases in hemoglobin Blood loss as estimated by postoperative decreases in hemoglobin Blood Loss

研究概览

简要总结

Randomized comparison of patient outcomes following standard PCNL versus mini-PCNL.

详细描述

This study is a randomized controlled trial which compares the operative outcomes and complications of mini-percutaneous nephrolithotomy (mini-PCNL) versus standard PCNL for renal stones. This study will be a multi-institutional, prospective randomized controlled clinical trial with patients who have already agreed to undergo PCNL. Patients will be randomized at a 1:1 ratio to receive either standard PCNL or mini-PCNL, defined as tract sizes of 30 and 16.5 to 18 French respectively. Patients will be asked to complete pre-operative, and post-operative quality of life questionnaires, and to allow collection of one additional vial of blood for measurement of factors associated with inflammation. The participating institutions are academic medical centers in the United States and Canada that are part of the EDGE research consortium.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients planned for PCNL at participating institutions
  • Age ≥ 18 years old
  • Male and female patients
  • Patients of all ethnic backgrounds
  • Stone size 10-20mm
  • Patients must be capable of giving informed consent and must be capable and willing to enroll and participate fully with the study.

排除标准

  • Conversion to open procedure
  • Multiple access tracts
  • Anticoagulated or history of coagulopathy
  • Preoperative ureteral stent or nephrostomy tube placement
  • Technical problems/impossibility of localizing the stone on the day of intervention
  • Patients unable to give informed consent or unwilling to enroll or participate in the study will be excluded.

研究组 & 干预措施

Standard PCNL

Active Comparator

Patients receive a standard PCNL procedure using a 24 fr tract

干预措施: PCNL (Procedure)

Mini-PCNL

Active Comparator

Patients receive a mini-PCNL procedure using a 16 fr tract

干预措施: PCNL (Procedure)

结局指标

主要结局

Blood loss as estimated by postoperative decreases in hemoglobin Blood loss as estimated by postoperative decreases in hemoglobin Blood Loss

时间窗: Post-operative day 1

Blood loss as estimated by postoperative decreases in hemoglobin Blood loss as estimated by postoperative decreases in hemoglobin Blood loss as estimated by postoperative decreases in hemoglobin Blood loss as estimated by postoperative decreases in hemoglobin Post-op decreases in hemoglobin

次要结局

  • Procalcitonin- Inflammatory Markers(Post operative day 1)
  • Surgical outcomes(30 Days)
  • Complication Rates(30 Days)
  • IL-6 Inflammatory Markers(Post operative day 1)
  • Renal Pelvis Pressures(Intraoperative)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验